Clinical Trials
In Parkinsons 2026, this session focuses on clinical trials in Parkinsons disease, highlighting studies of new drugs, therapies, and Surgery-based interventions. It explores the role of Genetics in personalized medicine, insights from Alzheimer research, and the contribution of Epidemiology to trial design, recruitment, and treatment evaluation.
Tracks:
Track 19.1: Trial Design
Track 19.2: Drug Trials
Track 19.3: Therapeutic Studies
Track 19.4: Patient Recruitment
Track 19.5: Clinical Endpoints